Filing Date: 2007-02-28.- Priority Data: US 60/813,606 (2006-02-28).The present invention relates to combinations of aplidine or aplidine analogues with other antitumoral agents, and the use of these combinations in the treatment of cancer, in particular in the treatment of lung cancer, breast cancer, colon cancer, prostate cancer, renal cancer, melanoma, multiple myeloma, leukemia and lymphoma.Pharma Mar, S.A.U.Peer reviewed